Ask me later

Ask me later

How likely are you to recommend Redeye to a friend or colleague?

1

2

3

4

5

6

7

8

9

10

Not likely

Very likely

Not likely

1

2

3

4

5

6

7

8

9

10

Very likely

Message received

Thanks again for rating us!

Alzecure: Interview with CEO Martin Jönsson and CSO Johan Sandin (video)

AH

Anders Hedlund

2021-04-20

13:51

Following reported phase 1b results with drug candidate ACD440, we seized the opportunity to interview CEO Martin Jönsson and CSO Johan Sandin at Alzecure Pharma. In this interview, Martin and Johan elaborate on why they are enthusiastic about the results and the path forward in peripheral neuropathic pain.

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers